ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.
"The American College of Radiology seeks and encourages collaboration with other organizations on the development of the ACR Appropriateness Criteria through society representation on expert panels. Participation by representatives from collaborating societies on the expert panel does not necessarily imply society endorsement of the final document."
Gopal
Ramesh S
RS
University of Texas M D Anderson Cancer Center, Houston, TX, USA. rgopal@mdanderson.org
Dubey
Sarita
S
Rosenzweig
Kenneth E
KE
Chang
Joe Yujiao
JY
Decker
Roy
R
Gewanter
Richard M
RM
Kong
Feng-Ming
FM
Lally
Brian E
BE
Langer
Corey J
CJ
Lee
Hoon Ku
HK
Movsas
Benjamin
B
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D020360:Neoadjuvant Therapy / Q000379:methods; D009367:Neoplasm Staging; D011182:Postoperative Care / Q000379:methods; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D012955:Societies, Medical; D014481:United States